Rhythm Pharmaceuticals Inc.
RYTM | NASDAQ
$105.02
-$5.66 (-5.11%)
At close: Nov 5, 2026, 4:00 PM ET
$104.97
-$0.05 (-0.05%)
After-hours:
Nov 5, 2026, 5:53 PM ET
Fiscal Quarter Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 92.13M | 71.26M | 60.11M | 57.25M | 51.3M | 48.5M | 32.7M | 41.83M | 33.25M | 29.08M | 25.97M | 24.23M | 22.5M | 19.22M | 11.47M | 8.79M | 4.28M | 9.07M | 1.5M | 1.82M | 1.03M | 274K | 35K |
Cost of Revenue | 12.17M | 8.93M | 7.16M | 4.8M | 5.5M | 5.54M | 3.65M | 3.79M | 3.83M | 2.95M | 2.81M | 3.23M | 2.41M | 2.24M | 1.42M | 1.03M | 497K | 378K | 230K | 236K | 222K | 137K | 4K |
Gross Profit | 79.96M | 62.32M | 52.96M | 52.45M | 45.8M | 42.96M | 29.06M | 38.04M | 29.42M | 26.13M | 23.16M | 21M | 20.09M | 16.99M | 10.05M | 7.76M | 3.79M | 8.69M | 1.27M | 1.58M | 806K | 137K | 31K |
Operating Income | -39.27M | -48.55M | -52.36M | -47.06M | -52.65M | -45.3M | -47M | -41.26M | -43.89M | -40.48M | -139.89M | -41.27M | -43.95M | -46.6M | -52.53M | -42.1M | -39.27M | -45.1M | -52.69M | -50.99M | -44.24M | -40.43M | -34.4M |
Interest Income | 3.16M | 3.22M | 3.55M | 4.09M | 4.33M | 3.24M | 3.64M | 3.52M | 4.05M | 4.1M | 3.05M | 3.82M | 3.47M | 3.22M | 3.44M | 3.04M | 920K | 274K | 160K | 134K | 138K | 21K | 154K |
Pretax Income | -40.76M | -48.85M | -55.09M | -47.54M | -52.79M | -46.3M | -49.42M | -43.38M | -43.99M | -31.78M | -141.07M | -41.44M | -43.8M | -46.7M | -52.18M | -42.49M | -40.86M | -45M | -52.76M | -50.86M | -44.1M | -40.41M | 65.76M |
Net Income | -41.37M | -49.3M | -55.64M | -47.51M | -52.9M | -46.63M | -49.5M | -43.29M | -43.64M | -32.26M | -141.37M | -41.63M | -44.16M | -46.7M | -52.18M | -42.49M | -40.86M | -45M | -52.76M | -42.87M | -35.11M | -35.39M | 43.75M |
Selling & General & Admin | 66.75M | 67.45M | 63.59M | 57.48M | 52.43M | 45.95M | 39.09M | 38.13M | 35.38M | 36.42M | 34.38M | 32.37M | 30.48M | 30.05M | 24.63M | 26.32M | 21.94M | 22.33M | 21.45M | 21M | 17.51M | 15.47M | 14.52M |
Research & Development | 52.48M | 43.43M | 41.73M | 42.03M | 46.03M | 42.31M | 36.97M | 41.17M | 37.93M | 30.02M | 128.47M | 29.89M | 33.57M | 33.54M | 37.95M | 23.55M | 21.12M | 31.46M | 32.51M | 31.57M | 27.54M | 25.1M | 19.91M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 119.23M | 110.88M | 105.32M | 99.51M | 98.45M | 88.26M | 76.06M | 79.3M | 73.31M | 66.61M | 163.05M | 62.27M | 64.05M | 63.59M | 62.58M | 49.87M | 43.05M | 53.78M | 53.96M | 52.57M | 45.05M | 40.57M | 34.43M |
Interest Expense | 4.5M | 4.54M | 4.58M | 4.62M | 4.74M | 5.82M | 5.41M | 5.45M | 5.24M | 4.6M | 4.76M | 4.55M | 3.15M | 3.3M | 3.06M | 3.01M | 2.14M | 46K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 131.4M | 119.81M | 112.47M | 104.32M | 103.95M | 93.8M | 79.71M | 83.09M | 77.14M | 69.56M | 165.85M | 65.5M | 66.46M | 65.83M | 64M | 50.89M | 43.55M | 54.16M | 54.19M | 52.81M | 45.27M | 40.71M | 34.43M |
Income Tax Expense | 610K | 444K | 545K | -31K | 111K | 337K | 80K | -90K | -344K | 479K | 300K | 196K | 368K | n/a | n/a | n/a | n/a | n/a | n/a | -7.99M | -9M | -5.02M | 22.01M |
Shares Outstanding (Basic) | 69.05M | 68.59M | 67.97M | 66.88M | 64.35M | 63.68M | 63.06M | 61.6M | 61.22M | 61.01M | 60.14M | 59.21M | 57.87M | 56.87M | 56.71M | 56.3M | 51.4M | 50.4M | 50.25M | 50.27M | 50.25M | 50.21M | 47.64M |
Shares Outstanding (Diluted) | 69.05M | 68.59M | 67.97M | 66.88M | 64.35M | 63.68M | 63.06M | 61.6M | 61.22M | 61.01M | 60.14M | 59.21M | 57.87M | 56.87M | 56.71M | 56.3M | 51.4M | 50.4M | 50.33M | 50.27M | 50.25M | 50.21M | 48.5M |
EPS (Basic) | -0.61 | -0.73 | -0.83 | -0.73 | -0.82 | -0.75 | -0.81 | -0.72 | -0.71 | -0.53 | -2.35 | -0.70 | -0.76 | -0.82 | -0.91 | -0.75 | -0.83 | -0.89 | -1.05 | -0.85 | -0.70 | -0.70 | 0.92 |
EPS (Diluted) | -0.61 | -0.73 | -0.83 | -0.73 | -0.82 | -0.75 | -0.81 | -0.72 | -0.71 | -0.53 | -2.35 | -0.70 | -0.76 | -0.82 | -0.91 | -0.75 | -0.83 | -0.89 | -1.05 | -0.85 | -0.70 | -0.70 | 0.90 |
EBITDA | -36.26M | -44.06M | -50.26M | -42.65M | -47.75M | -40.1M | -43.63M | -37.55M | -38.36M | -26.79M | -135.91M | -36.47M | -40.2M | -42.96M | -48.66M | -39.04M | -38.28M | -44.52M | -52.41M | -50.53M | -43.79M | -40.09M | -34.2M |
EBIT | -36.26M | -44.31M | -50.51M | -42.92M | -48.05M | -40.48M | -44.01M | -37.94M | -38.74M | -27.18M | -136.32M | -36.89M | -40.65M | -43.4M | -49.12M | -39.48M | -38.72M | -44.96M | -52.76M | -50.86M | -44.1M | -40.41M | -34.4M |
Depreciation & Amortization | n/a | 251K | 252K | 272K | 304K | 379K | 383K | 383K | 385K | 390K | 405K | 417K | 442K | 442K | 457K | 442K | 442K | 438K | 350K | 325K | 315K | 317K | 201K |
Add to Watchlist
Select watchlists to add or remove RYTM